IE45030L - Aminoglycoside antibiotics and their intermediates - Google Patents

Aminoglycoside antibiotics and their intermediates

Info

Publication number
IE45030L
IE45030L IE770761A IE76177A IE45030L IE 45030 L IE45030 L IE 45030L IE 770761 A IE770761 A IE 770761A IE 76177 A IE76177 A IE 76177A IE 45030 L IE45030 L IE 45030L
Authority
IE
Ireland
Prior art keywords
group
groups
formula
amino
hydroxyl
Prior art date
Application number
IE770761A
Other versions
IE45030B1 (en
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of IE45030L publication Critical patent/IE45030L/en
Publication of IE45030B1 publication Critical patent/IE45030B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The kanamycin derivatives of formula I, in which R is an amino or hydroxyl group and R<1> is an alkyl group optionally substituted by hydroxyl and/or amino groups, are obtained by alkylation of the compounds of formula II, in which R<2> is H or a benzyl group, R<3> is an acyl-protecting group and R<4> is a hydroxyl group or an NHR<3> group, followed by the removal of the R<3> groups and the benzyl group R<2>, where appropriate. The compounds of formula II are new intermediates which are obtained by acylation of a kanamycin A, B or a 3-N-benzylkanamycin A, protected on all its amino functional groups, followed by the removal of the protecting groups and the intramolecular migration of the acyl group from oxygen to nitrogen. <IMAGE> [GB1530201A]
IE761/77A 1976-04-14 1977-04-13 Process for the preparation of aminoglycoside antibiotics and novel intermediates therefor IE45030B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB15421/76A GB1530201A (en) 1976-04-14 1976-04-14 Process for the preparation of aminoglycoside antibiotics and intermediates therefor

Publications (2)

Publication Number Publication Date
IE45030L true IE45030L (en) 1977-10-14
IE45030B1 IE45030B1 (en) 1982-06-02

Family

ID=10058845

Family Applications (1)

Application Number Title Priority Date Filing Date
IE761/77A IE45030B1 (en) 1976-04-14 1977-04-13 Process for the preparation of aminoglycoside antibiotics and novel intermediates therefor

Country Status (28)

Country Link
JP (2) JPS52139044A (en)
AR (1) AR219074A1 (en)
AT (1) AT356267B (en)
AU (1) AU497416B2 (en)
BE (1) BE853564A (en)
BG (2) BG27759A3 (en)
CA (1) CA1083568A (en)
CH (1) CH622528A5 (en)
CS (1) CS202570B2 (en)
DD (2) DD130661A5 (en)
DE (1) DE2716533C3 (en)
DK (1) DK164277A (en)
EG (1) EG12909A (en)
ES (1) ES457793A1 (en)
FI (1) FI771144A (en)
FR (1) FR2348223A1 (en)
GB (1) GB1530201A (en)
GR (1) GR68936B (en)
IE (1) IE45030B1 (en)
IL (1) IL51775A (en)
LU (1) LU77108A1 (en)
NL (1) NL7703567A (en)
NZ (1) NZ183733A (en)
PH (1) PH14029A (en)
PL (2) PL197372A1 (en)
PT (1) PT66422B (en)
RO (2) RO74431A (en)
ZA (1) ZA771944B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2924659A1 (en) * 1979-06-19 1981-01-22 Bayer Ag PSEUDOTRISACCHARIDE, THEIR PRODUCTION AND USE AS A MEDICINAL PRODUCT
JPH0414628Y2 (en) * 1984-12-13 1992-04-02
JPS61191642U (en) * 1985-05-20 1986-11-28
IT1225484B (en) * 1987-11-27 1990-11-14 Pierrel Spa SYNTHESIS PROCEDURE OF AMIKACINA
CN101481397B (en) * 2009-01-23 2012-10-31 北京大学 Novel kanamycin A derivative, and preparation and use thereof
BR112013010157B1 (en) 2010-11-08 2020-02-04 Albireo Ab ibat inhibitors, their uses, and pharmaceutical composition and combinations
JP6581082B2 (en) 2014-06-25 2019-09-25 Eaファーマ株式会社 Solid preparation and method for stabilizing the same
CN106659726A (en) 2014-06-25 2017-05-10 Ea制药株式会社 Solid preparation, and method for preventing or reducing discoloration thereof
EP3012252A1 (en) 2014-10-24 2016-04-27 Ferring BV Crystal modifications of elobixibat
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
US10786529B2 (en) 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof

Also Published As

Publication number Publication date
BG27759A3 (en) 1979-12-12
DE2716533A1 (en) 1977-11-03
GB1530201A (en) 1978-10-25
FR2348223A1 (en) 1977-11-10
ES457793A1 (en) 1978-08-01
ATA261477A (en) 1979-09-15
AU497416B2 (en) 1978-12-14
AU2372177A (en) 1978-10-05
RO79969A (en) 1983-02-01
ZA771944B (en) 1978-03-29
PT66422A (en) 1977-05-01
AT356267B (en) 1980-04-25
DE2716533B2 (en) 1981-04-30
IE45030B1 (en) 1982-06-02
DD135496A5 (en) 1979-05-09
JPS535141A (en) 1978-01-18
JPS52139044A (en) 1977-11-19
NL7703567A (en) 1977-10-18
RO79969B (en) 1983-01-30
NZ183733A (en) 1979-12-11
PL197372A1 (en) 1979-06-18
BE853564A (en) 1977-10-13
DD130661A5 (en) 1978-04-19
JPS5549587B2 (en) 1980-12-12
GR68936B (en) 1982-03-29
DK164277A (en) 1977-10-15
EG12909A (en) 1979-12-31
IL51775A (en) 1980-07-31
PL112867B1 (en) 1980-11-29
CS202570B2 (en) 1981-01-30
RO74431A (en) 1981-08-30
FI771144A (en) 1977-10-15
DE2716533C3 (en) 1982-05-13
BG28072A4 (en) 1980-02-25
JPS5421326B2 (en) 1979-07-30
PH14029A (en) 1980-12-12
IL51775A0 (en) 1977-05-31
LU77108A1 (en) 1979-01-18
CA1083568A (en) 1980-08-12
AR219074A1 (en) 1980-07-31
PT66422B (en) 1978-09-18
CH622528A5 (en) 1981-04-15

Similar Documents

Publication Publication Date Title
IE45030L (en) Aminoglycoside antibiotics and their intermediates
IE810230L (en) Beta-lactams.
JPS5368752A (en) 4-n-acyl fortimicin b derivatives and their preparation
ES467601A1 (en) 7[(2-Amino-thiazol-4-yl)glyoxylamido]-cephem derivatives and processes for their preparation
IT1166021B (en) PROCEDURE FOR THE PRODUCTION OF A SELECTIVELY PROTECTED N ACYLATED DERIVATIVE OF AN AMINO GLYCASIDIC ANTIBIOTIC
BR8006156A (en) MEANS OF DETECTION OF ROUTE TIME AND SPEED OF THE PRINTER HAMMER BY IMPACT
JPS5356661A (en) Novel amino glycoside antibiotics derivatives
GB1480772A (en) Antibiotic derivatives
AU520924B2 (en) Jacket for small arms projectile to prevent expansion upon impact
IE782502L (en) Cephalosporins
FR2306698A1 (en) CRYSTALLINE FORM OF AN ANTIBIOTIC
IE41590L (en) Cephalosporin compounds
IE780841L (en) Kanamycin derivatives
IE781653L (en) Kanamycins
AU503385B2 (en) Engine cylinder identification
GR74128B (en)
JPS53141244A (en) Novel hortemycin derivatives
IE44230L (en) 1, 3-diaza-bicyclo [3,2, 0] heptane derivatives
BE882980A (en) EPIMER D OF DIAMMONIUM SALT OF AN OXA-BETA-LACTAME ANTIBIOTIC
BE882849A (en) CRYSTALLIZATION OF THE SESQUI-SODIUM SALT OF AN ANTIBIOTIC OXA-BETA LACTAM DIACIDE
SU646192A1 (en) Pneumatic weapon
FI834594A0 (en) ANTIBIOTICS A51568 FACTORERNA A OCH B
IT1129789B (en) PRINT CYLINDER WITH RUBBER COATING
AU501516B2 (en) N-(6-acyloxybenzothiazo-2-yl)-n&#39;-phenyl (or substituted phenyl) ureas
CA1021199A (en) High speed impact printer